Methyclothiazide - Moligand™, 10mM in DMSO , Thiazide-sensitive sodium-chloride cotransporter inhibitor, CAS No.135-07-9, Thiazide-sensitive sodium-chloride cotransporter inhibitor

CAS: 135-07-9 Cat. No.: M408281 분자식: C₉H₁₁Cl₂N₃O₄S₂ 분자량: 360.24

GRADE & PURITY Moligand™, 10mM in DMSO

Synonyms

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

개요

Information

Methyclothiazide is a substituted benzothiadiazide, used to treat high blood pressure and fluid retention caused by various conditions including heart disease.
In vitro

Methyclothiazide (0.1 mM) reduces Ca²⁺ contractures with maximal inhibition of 90.4% in SHR aortic rings with endothelium. The inhibitory effect of Methyclothiazide (0.1 mM) on Ca²⁺ contracture is significantly but not totally abolished by the NO synthase inhibitor in SHR aortic rings with functional endothelium. Methyclothiazide (0.1 mM) induces endothelium-dependent inhibition of the vasoconstrictor responses to NE and AVP only in aortas from spontaneously hypertensive rats (SHR) rather than normotensive Wistar Kyoto rats (WKY), and the maximal vasoconstrictive effect of NE and AVP is decreased by 59% and 32.3%, respectively. Methyclothiazide (3.5 mM) inhibits renin release in rat kidney slices.

In vivo

Methyclothiazide (0.1 g/L for the first 5 weeks and 0.2 g/L for the second 2 weeks, drinking water) attenuates development of hypertension in salt-sensitive (DS) rats, but does not affect blood pressure in salt-resistant (DR) ones. The methyclothiazide-treated DOCA-salt rats weigh less than controls or the nonsupplemented DOCA-salt rats at weeks 3 and 4. Methyclothiazide added to the drinking water of DOCA-salt rats attenuates the elevation of blood pressure.
Cell Data

cell lines：PC12 cell

Concentrations：

Incubation Time：

Powder Purity:≥99%

Specifications

동의어

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide

사양 및 순도

Moligand™, 10mM in DMSO

생화학 및 생리적 메커니즘

Methyclothiazide is a substituted benzothiadiazide, used to treat high blood pressure and fluid retention caused by various conditions including heart disease.

보관 조건

Store at -80°C

배송

Dry ice packs + Cold packs

이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.

등급

Moligand™

작업 유형

INHIBITOR

작동 메커니즘

Thiazide-sensitive sodium-chloride cotransporter inhibitor

제품 특성

ALogP

1.4

이름과 식별자

이성체 SMILES

CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl

분자량

360.24

Reaxy-Rn

765361

Reaxys-RN_link_address

https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=765361&ln=